文献速递胸部技术与安全CT

CT与逆转录聚合酶链反应对2019冠状病毒病的诊断效能:一项Meta分析

Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis.
PubMed 文献 · Radiology · 2020-04-17

该Meta分析检索2020年1月1日至2020年4月3日Medline和Embase数据库,评估胸部CT与初始RT-PCR对COVID-19的诊断效能。胸部CT汇总敏感度94%、特异度37%,RT-PCR汇总敏感度89%;在中国以外患病率1.0%–22.9%时,CT阳性预测值仅1.5%–30.7%。

要点

  • 胸部CT汇总敏感度94%、特异度37%,RT-PCR汇总敏感度89%。
  • 中国以外患病率1.0%–22.9%时,CT阳性预测值1.5%–30.7%,阴性预测值95.4%–99.8%。
  • RT-PCR阳性预测值47.3%–96.4%,阴性预测值96.8%–99.9%。

诊断标准与关键数值

  • 胸部CT汇总敏感度94%(95%CI:91%,96%;I²=95%),汇总特异度37%(95%CI:26%,50%;I²=83%)。
  • RT-PCR汇总敏感度89%(95%CI:81%,94%;I²=90%)。
  • 中国以外患病率1.0%–22.9%时,胸部CT阳性预测值1.5%–30.7%,阴性预测值95.4%–99.8%。
  • RT-PCR阳性预测值47.3%–96.4%,阴性预测值96.8%–99.9%。

临床应用与阅片要点

  • 胸部CT敏感度高但特异度低(37%),在低患病率地区阳性预测值低,阅片阳性结果需结合RT-PCR。
  • CT敏感度受疾病严重程度分布、合并症患者比例和无症状患者比例影响(均P<.05)。
  • RT-PCR敏感度与老年患者比例呈负相关(P=.01)。

局限性

  • 胸部CT汇总敏感度异质性I²=95%,特异度异质性I²=83%。
  • RT-PCR汇总敏感度异质性I²=90%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Recent studies have suggested that chest CT scans could be used as a primary screening or diagnostic tool for coronavirus disease 2019 (COVID-19) in epidemic areas. Purpose To perform a meta-analysis to evaluate diagnostic performance measures, including predictive values of chest CT and initial reverse transcriptase polymerase chain reaction (RT-PCR). Materials and Methods Medline and Embase were searched from January 1, 2020, to April 3, 2020, for studies on COVID-19 that reported the sensitivity, specificity, or both of CT scans, RT-PCR assays, or both. The pooled sensitivity and specificity were estimated by using random-effects models. The actual prevalence (ie, the proportion of confirmed patients among those tested) in eight countries was obtained from web sources, and the predictive values were calculated. Meta-regression was performed to reveal the effect of potential explanatory factors on the diagnostic performance measures. Results The pooled sensitivity was 94% (95% confidence interval [CI]: 91%, 96%; I2 = 95%) for chest CT and 89% (95% CI: 81%, 94%; I2 = 90%) for RT-PCR. The pooled specificity was 37% (95% CI: 26%, 50%; I2 = 83%) for chest CT. The prevalence of COVID-19 outside China ranged from 1.0% to 22.9%. For chest CT scans, the positive predictive value (PPV) ranged from 1.5% to 30.7%, and the negative predictive value (NPV) ranged from 95.4% to 99.8%. For RT-PCR, the PPV ranged from 47.3% to 96.4%, whereas the NPV ranged from 96.8% to 99.9%. The sensitivity of CT was affected by the distribution of disease severity, the proportion of patients with comorbidities, and the proportion of asymptomatic patients (all P < .05). The sensitivity of RT-PCR was negatively associated with the proportion of elderly patients (P = .01). Conclusion Outside of China where there is a low prevalence of coronavirus disease 2019 (range, 1%-22.9%), chest CT screening of patients with suspected disease had low positive predictive value (range, 1.5%-30.7%). © RSNA, 2020 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kim H, Hong H, Yoon SH, et al. Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis. Radiology. 2020. PMID: 32301646. doi:10.1148/radiol.2020201343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。